Mechanism of Action of Heparin
The mechanism of action of heparin is potentiation of antithrombin III action (option d), as heparin binds to antithrombin through a specific pentasaccharide sequence, causing a conformational change that dramatically enhances antithrombin's ability to inhibit multiple coagulation enzymes, particularly thrombin (Factor IIa) and Factor Xa. 1, 2, 3
Primary Mechanism: Antithrombin III Potentiation
Heparin works primarily through its interaction with antithrombin (formerly called antithrombin III or AT-III). This interaction occurs through the following steps:
- Heparin binds to lysine sites on antithrombin through a unique pentasaccharide sequence 1
- This binding induces a conformational change in antithrombin's structure 2
- The conformational change converts antithrombin from a slow, progressive inhibitor to a very rapid inhibitor of serine proteases 1, 3
- The heparin-antithrombin complex then inactivates multiple coagulation enzymes 1
- After antithrombin binds covalently to the active serine center of coagulation enzymes, heparin dissociates from the complex and can be reused 1, 2
Target Coagulation Factors
The heparin-antithrombin complex inhibits several coagulation enzymes, with varying degrees of sensitivity:
- Thrombin (Factor IIa) - most sensitive, approximately 10-fold more sensitive than Factor Xa 1
- Factor Xa - second most sensitive 1
- Factors IXa, XIa, and XIIa - also inhibited but to a lesser extent 1, 2
Important Structural Requirements
The molecular structure of heparin is critical to its function:
- Only approximately one-third of administered heparin contains the high-affinity pentasaccharide sequence required for binding to antithrombin 1, 2
- For thrombin inhibition, heparin molecules must have at least 18 saccharides to bind simultaneously to both thrombin and antithrombin 1
- Smaller heparin fragments containing the pentasaccharide sequence can still catalyze inhibition of Factor Xa but cannot inhibit thrombin 1
Secondary Mechanisms
At higher concentrations, heparin exhibits additional mechanisms:
- Activation of heparin cofactor II, which specifically inhibits thrombin 1, 2
- Binding to platelets, which can affect platelet function 1
- Prevention of fibrin clot formation by inhibiting the activation of fibrin stabilizing factor 3
Why Other Options Are Incorrect
- (a) Direct inhibition of thrombin - Incorrect because heparin does not directly inhibit thrombin but rather potentiates antithrombin's inhibitory action 1, 3
- (b) Prevention of factor II synthesis - Incorrect because heparin does not affect the synthesis of coagulation factors (this is the mechanism of vitamin K antagonists like warfarin) 3
- (c) Inhibition of cyclo-oxygenase - Incorrect because this is the mechanism of action for aspirin and other non-steroidal anti-inflammatory drugs, not heparin 3
Heparin's heterogeneity (molecular weight range 3,000-30,000 Da) contributes to its complex pharmacology and variable anticoagulant response in clinical practice 1, 2.